Mallardi Antonia

Dr. Mallardi Antonia


Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2014 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
Gerardo PalazzoGerardo Palazzo
Gerardo Palazzo
DTDonato De Tullio
Donato De Tullio
MMMaria Magliulo
Maria Magliulo
MAMallardi Antonia
Mallardi Antonia
FIFrancesca Intranuovo
Francesca Intranuovo
Luisa TorsiLuisa Torsi
Luisa Torsi

3 January 2013 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
MMMaria Magliulo
Maria Magliulo
MAMallardi Antonia
Mallardi Antonia
MMMohammad Yusuf Shafi Mulla
Mohammad Yusuf Shafi Mulla
SCSerafina Cotrone
Serafina Cotrone
BPBianca Rita Pistillo
Bianca Rita Pistillo
Luisa TorsiLuisa Torsi
Luisa Torsi

1 September 2011 in Materials Today
Verified
Journal Article
Open access
MAMaria D. Angione
Maria D. Angione
Rosa PilolliRosa Pilolli
Rosa Pilolli
SCSerafina Cotrone
Serafina Cotrone
MMMaria Magliulo
Maria Magliulo
MAMallardi Antonia
Mallardi Antonia
Luisa TorsiLuisa Torsi
Luisa Torsi

9 April 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MAMaria Daniela Angione
Maria Daniela Angione
SCSerafina Cotrone
Serafina Cotrone
MMMaria Magliulo
Maria Magliulo
MAMallardi Antonia
Mallardi Antonia
DADavide Altamura
Davide Altamura
Luisa TorsiLuisa Torsi
Luisa Torsi
Biosystems integration into an organic field-effect transistor (OFET) structure is achieved by spin coating phospholipid or protein layers between the gate dielectric and the organic semiconductor. An architecture directly interfacing supported biological layers to the OFET channel is proposed and, strikingly, both the electronic properties and the biointerlayer functionality are fully retained. The platform bench tests involved OFETs integrating phospholipids and bacteriorhodopsin exposed to 1–5% anesthetic doses that reveal drug-induced changes in the lipid membrane. This result challenges the current anesthetic action model relying on the so far provided evidence that doses much higher than clinically relevant ones (2.4%) do not alter lipid bilayers’ structure significantly. Furthermore, a streptavidin embedding OFET shows label-free biotin electronic detection at 10 parts-per-trillion concentration level, reaching state-of-the-art fluorescent assay performances. These examples show how the proposed bioelectronic platform, besides resulting in extremely performing biosensors, can open insights into biologically relevant phenomena involving membrane weak interfacial modifications.

9 July 2008 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
FFFrancesco Francia
Francesco Francia
MDManuela Dezi
Manuela Dezi
MAMallardi Antonia
Mallardi Antonia
Gerardo PalazzoGerardo Palazzo
Gerardo Palazzo
LCLorenzo Cordone
Lorenzo Cordone
GVGiovanni Venturoli
Giovanni Venturoli

1 February 2002 in Biophysical Journal
Verified
Journal Article
Closed access
Gerardo PalazzoGerardo Palazzo
Gerardo Palazzo
MAMallardi Antonia
Mallardi Antonia
AHAlejandro Hochkoeppler
Alejandro Hochkoeppler
LCLorenzo Cordone
Lorenzo Cordone
GVGiovanni Venturoli
Giovanni Venturoli